Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Inhibition of Breast Cancer Cell Growth and Migration Through Sirna-Mediated Modulation of Circ_0009910/Mir-145-5P/Muc1 Axis Publisher



Abtin M1 ; Nafisi N2 ; Hosseinzadeh A1 ; Kadkhoda S1 ; Omranipour R3, 4 ; Sahebi L5 ; Razipour M1 ; Ghafourifard S6 ; Shakoori A1, 7
Authors

Source: Non-coding RNA Research Published:2024


Abstract

Circular RNAs (circRNAs) characterize a novel kind of regulatory RNAs distinguished by great evolutionary conservation and constancy. Although their exact role in malignancies is not fully understood, they mainly work through specific axes. Circular RNA/miRNA/mRNA axes affect the pathogenesis of human cancers including breast cancer. We assessed the expression and function of circ_0009910/miR-145-5p/MUC1 axis in Breast Cancer tissues and MCF-7 cells. Expression levels of circ_0009910 and MUC1 were notably increased in breast cancer tissues compared with control tissues, parallel with the down-regulation of miR-145-5p. Clinicopathological analysis indicated that up-regulation of circ_0009910 in breast tumors is related to invasion of the tumor to lymph node (P value = 0.011). Also, the downregulation of miR-145-5p was significantly correlated with tumor invasion to lymph nodes (P value = 0.04) and HER2-negative tumors (P value = 0.037). Finally, overexpression of MUC1 was correlated with age under 45 years (P value = 0.002). More importantly, circ_0009910-siRNA decreased the proliferation and migration ability of breast cancer cells, enhanced expression of miR-145-5p, and decreased levels of MUC1. Taken together, the circ_0009910/miR-145-5p/MUC1 axis has been demonstrated to affect the pathogenesis of breast cancer and might provide a target for breast cancer treatment. © 2024 The Authors
Other Related Docs
13. Circular Rnas in Laryngeal Cancer, Clinica Chimica Acta (2025)
14. Potential Roles of Hsa_Circ_000839 and Hsa_Circ_0005986 in Breast Cancer, Journal of Clinical Laboratory Analysis (2022)
20. Mir-495–3P As a Promising Tumor Suppressor in Human Cancers, Pathology Research and Practice (2023)